Results 161 to 170 of about 28,598,086 (367)
Cell‐free DNA aneuploidy score as a dynamic early response marker in prostate cancer
mFast‐SeqS‐based genome‐wide aneuploidy scores are concordant with aneuploidy scores obtained by whole genome sequencing from tumor tissue and can predict response to ARSI treatment at baseline and, at an early time point, to ARSI and taxanes. This assay can be easily performed at low cost and requires little input of cfDNA. Cell‐free circulating tumor
Khrystany T. Isebia+17 more
wiley +1 more source
Journal of Control Science and Engineering
doaj +1 more source
Responses of the Human Eccrine Sweat Duct to Controlled Injury
Walter C. Lobitz+2 more
openalex +1 more source
MET variants in the N‐lobe of the kinase domain, found in hereditary papillary renal cell carcinoma, require ligand stimulation to promote cell transformation, in contrast to other RTK variants. This suggests that HGF expression in the microenvironment is important for tumor growth in such patients. Their sensitivity to MET inhibitors opens the way for
Célia Guérin+14 more
wiley +1 more source
Wind turbine control with constraint handling: a model predictive control approach [PDF]
Henriksen+6 more
core +2 more sources
Journal of Control Science and Engineering
doaj +1 more source
What Are Nurses Doing to Help Control Communicable Disease? [PDF]
NULL AUTHOR_ID
openalex +1 more source
Epithelial–mesenchymal transition (EMT) and tumor‐infiltrating lymphocytes (TILs) are associated with early breast cancer response to neoadjuvant chemotherapy (NAC). This study evaluated EMT and TIL shifts, with immunofluorescence and RNA sequencing, at diagnosis and in residual tumors as potential biomarkers associated with treatment response.
Françoise Derouane+16 more
wiley +1 more source
Journal of Control Science and Engineering
doaj +1 more source